Ethicon, Gmbh

Other

Wyeth

Cordis Corporation

Cardinal Health Switzerland 515 Gmbh

Sorin Group Usa, Inc.

Kevin S. Weadock

Robert A. Rousseau

Kevin Shaun Weadock

Robert Anthony Rousseau

Leo B Kriksunov

Parris S Wellman

Robert J Tannhauser

David C Lindh, Sr

John R Jacobs

Julian A Quintero

James J Rudnick

Kevin D Trangone

David C Lindh

Frederick E Shelton, IV

Jason L Harris

Charles J Scheib

Michael J Vendely

Shailendra Kumar Parihar

Timothy G Dietz

John V Hunt

Simon Cohn

Thomas P Ryan

Michael Cardinale

William E Cohn

David L Hamann

Angelo G Scopelianos

Jessica Liberatore

Gerard H Llanos

Robert Nering

Mark B Roller

Howard A Stone

Prudence A Vulhop

Ashley DeAnglis

Bethany F Grant

Uri Herzberg

Rajesh Pendekanti

Nicholas B Van Stolk

An-Min Jason Sung

Salim A Ghodbane

Etan Chatlynne

Terry Daglow

Rudolph Cedro, Jr

Jeffrey T Hammond

David Lindh

Jennifer M Nagy

David Christian Lentz

Elliott J Fegelman

Peter Douglas

Daniel Gordon

Amit Khanolkar

Greg Scott

Carl J Evens

Philip Prentice

Shin-Yir C Tong

Robert S Casar

Raghuveer Basude

T Anh Le

Ben Kibalo

An-Amin Jason Sung

Martin Weisberg

Earl Adamy

David C Lentz

David Sr Lindh

Jeffrey Hammond

A system or device for skin closure comprises an elastic flat flexible tape elongated along a longitudinal axis and having a lower side and an opposing upper side, said tape having a pressure sensitive adhesive on at least a portion of the lower side, said tape having a plurality of openings arranged side-by-side with spaces between said openings oriented across the longitudinal axis.

Skin closure systems and devices of improved flexibility and stretchability for bendable joints

An implantable device for control over the size of emphysematous bullae in a lung, including: an elongated central region having a fixed axial length; a first end including a first anchor; and a second end including a second anchor.

Methods and devices for controlling the size of emphysematous bullae

A method and kit for stopping cerebrospinal fluid (CSF) leaks, comprising penetrating and passing through a dural tissue an applicator to access an interior dural space, injecting from the applicator a fibrinogen-containing solution into said dural space, applying a sealing member containing a fibrinogen polymerizing agent onto an exterior surface of the dural tissue, and forming a polymerized fibrinogen or polymerized fibrin clot by contacting the injected fibrinogen-containing solution and the fibrinogen polymerizing agent.

Method of stopping CSF leaks and apparatus therefor

A surgical stapler having an anvil including a plurality of staple forming pockets for forming staples. The staple forming pockets include first and second staple forming cups configured to receive first and second legs of a staple respectively. The first staple forming cup within each staple forming pocket has a different depth from the second staple forming cup within that staple forming pocket.

Anvil assembly for use with surgical stapling instruments

A method is used to reduce a volume of a stomach of a patient. The method includes inverting a portion of a stomach wall to thereby create an inverted portion. An expandable member is positioned adjacent to the outer surface of the inverted portion. The expandable member is expanded to thereby expand the inverted portion. The expanded expandable member has a first outer diameter. A base region of the inverted portion is cinched to thereby capture the expanded expandable member in the expanded inverted portion. The expanded expandable member has a first outer diameter. Expanding and cinching provide a cinch diameter to first outer diameter ratio from approximately 0.5:1 to approximately 0.9:1.

Apparatus and method for gastric volume reduction utilizing an expandable member

A method and apparatus for treatment of pulmonary conditions, including a device having an end effector sized and shaped to contact a nerve component on the exterior of a bronchial segment and apply energy to that nerve component.

Thoracoscopic methods for treatment of bronchial disease

An adjunct material for use with an end effector in a surgical instrument is provided that has at least one projection configured to mate with a corresponding recess formed in at least one jaw, such as a cartridge or anvil, of the end effector. The at least one projection can be one or more discrete projections or longitudinal projection(s) extending between distal and proximal ends of the adjunct material. An applicator member can be used to apply force to the adjunct material to thus cause the adjunct material to mate with the jaw of the end effector. The applicator member can be configured told the adjunct material and can be clamped between the jaws of the end effector to release the adjunct material onto the jaw. Also, an applicator member can be used to push portions of an adjunct material into corresponding recesses in a jaw.

End effector configured to mate with adjunct materials

A novel caloric bypass device that is inserted through the oral cavity and into the digestive tract of a human is disclosed. The device is deliverable as either a unitary or modular structure that preferentially directs a significant volume of the high calorie fluidic components of the chyme through the digestive tract, preventing exposure to the absorptive tissues of the digestive tract and, in some forms, stimulates negative feedback to the patient when simple sugars and carbohydrates are consumed. Also disclosed is a novel method of reducing or restricting caloric intake using this device to prevent or minimize contact with the absorptive tissues of the digestive tract.

Caloric bypass device

Novel systems for and methods of delivering therapeutic agents to target tissues are disclosed. The method of delivering a therapeutic agent to a target tissue involves identifying a target tissue via an imaging modality and then using a guidewire capable of anchoring in tissue to advance a cannula to the target tissue. The guidewire and novel cannula configurations enable rapid and repeated treatments of the target tissue without the need for subsequent imaging. The cannula is coupled to a source of ultrasound, radiation, radiofrequency energy, or chemotherapeutic agents which can then be delivered to from the cannula the target tissue. The system and method can be used to treat tumors that are small or surgically inoperable. In addition, the system can be used to treat lymphatic tissue that may contain metastases from the tumors.

System and method for targeted delivery of therapeutic agents to tissue

The present invention relates to surgical instruments and a method for applying an adhesive or sealant to an anastomosis site immediately prior and/or during anastomotic surgical stapling. The present invention further relates to surgical instruments, devices, and methods for applying sealant to a target tissue of a surgical site being anastomotically joined so as to prevent leakage.

Sealant delivery device for anastomotic stapler

A system for treating obstructive sleep apnea includes a first element implantable in a tongue and a second element implantable between muscle planes of an inframandibular region. The second element has a first end coupled with the first element and a second end coupled with a hyoid bone for preventing the base of the tongue from collapsing against an opposing pharyngeal wall during sleep. The first and second implantable elements have outer surfaces that are substantially impermeable to tissue in-growth to allow for post-surgical adjustment or removal, if necessary. The first implantable element is elongated and includes a first end, a second end, and a center section located between the first and second ends. The center section is implantable in the tongue, and the first and second ends of the first implantable element are advanceable beneath the tongue for being coupled with the anterior end of the second implantable element.

Tongue suspension system with hyoid-extender for treating obstructive sleep apnea

Methods and devices comprised of a collapsible insert member and shaping member for treating obstructive sleep apnea are described. The insert member is placed in the tongue or other tissue forming the airway of the patient and has a lumen to accommodate the shaping member. The shaping member is inserted into the insert member by the patient just prior to sleep and removed upon waking. A variety of shaping members are available to treat patients on an individual basis, i.e., to match their particular anatomic condition that is causing their apnea or snoring. The shaping member can be made from nitinol, stainless steel, or any other known biocompatible implant material capable of providing a change in the tissue response to stress.

Method and device for treating obstructive sleep apnea

This invention provides methods, devices and kits for treating coronary artery disease, particularly 'soft' or vulnerable plaque. The invention is based on the local delivery of crosslinking means to crosslink the collagen covering the plaque and other proteins that may be present at the site to stabilize the plaque and prevent leakage of thrombogenic material into the lumen of the coronary artery. In certain embodiments, catheters are employed to achieve local delivery of a crosslinking agent or ultraviolet light.

Methods and devices for treating vulnerable plaque

The present invention is related to a polymeric vehicle for delivery of bioactive agents, and preferably, for the delivery of one or more bioactive agents. The invention is also directed to a percutaneous device securing and drug delivery device comprising, as a component thereof, a material which delivers antimicrobial and/or other wound-healing factors at the site of the insertion of the catheter into the body. The device, when applied as described herein, provides complete anti-microbial coverage around the entry point of a percutaneous device and, preferably for a length greater than the diameter of the device. The present invention is also directed to methods for using such devices in combination with percutaneous devices primarily to reduce site infections.

Antimicrobial dressing providing percutaneous device securement and cover

Growing community of inventors

Hillsborough, NJ, United States of America

Kevin Shaun Weadock